Cite
McFarland MS, Huddleston L, Tammareddi K, et al. Comparison of hemoglobin A1c goal achievement with the addition of pioglitazone to maximal/highest tolerated doses of sulfonylurea and metformin combination therapy. J Drug Assess. 2012;1(1):34-9doi: 10.3109/21556660.2012.707996.
McFarland, M. S., Huddleston, L., Tammareddi, K., McKenzie, M., & Bean, J. (2012). Comparison of hemoglobin A1c goal achievement with the addition of pioglitazone to maximal/highest tolerated doses of sulfonylurea and metformin combination therapy. Journal of drug assessment, 1(1), 34-9. https://doi.org/10.3109/21556660.2012.707996
McFarland, M Shawn, et al. "Comparison of hemoglobin A1c goal achievement with the addition of pioglitazone to maximal/highest tolerated doses of sulfonylurea and metformin combination therapy." Journal of drug assessment vol. 1,1 (2012): 34-9. doi: https://doi.org/10.3109/21556660.2012.707996
McFarland MS, Huddleston L, Tammareddi K, McKenzie M, Bean J. Comparison of hemoglobin A1c goal achievement with the addition of pioglitazone to maximal/highest tolerated doses of sulfonylurea and metformin combination therapy. J Drug Assess. 2012 Jun 29;1(1):34-9. doi: 10.3109/21556660.2012.707996. eCollection 2012. PMID: 27536426; PMCID: PMC4980726.
Copy
Download .nbib